Do analysts rate BFRG or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or VIVS more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% VivoSim Labs -11,016.07% -612.23% -177.02%

Does the media prefer BFRG or VIVS?

In the previous week, VivoSim Labs had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 5 mentions for VivoSim Labs and 4 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that VivoSim Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral VivoSim Labs 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ISPC or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, ISPC or VIVS?

iSpecimen has higher revenue and earnings than VivoSim Labs. VivoSim Labs is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.48 -$10.49M -$56.44 N/A VivoSim Labs $130K 22.98 -$13.84M -$4.47 N/A

Is ISPC or VIVS more profitable?

iSpecimen has a net margin of -2,445.40% compared to VivoSim Labs' net margin of -11,016.07%. iSpecimen's return on equity of -524.39% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -2,445.40% -524.39% -140.42% VivoSim Labs -11,016.07% -612.23% -177.02%

Does the media prefer ISPC or VIVS?

In the previous week, VivoSim Labs had 3 more articles in the media than iSpecimen. MarketBeat recorded 5 mentions for VivoSim Labs and 2 mentions for iSpecimen. VivoSim Labs' average media sentiment score of 0.90 beat iSpecimen's score of 0.90 indicating that VivoSim Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iSpecimen 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive VivoSim Labs 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate VIVS or BFRGW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, VIVS or BFRGW?

Bullfrog AI has higher revenue and earnings than VivoSim Labs. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VivoSim Labs $130K 22.98 -$13.84M -$4.47 N/A Bullfrog AI $298.80K N/A N/A N/A N/A

Is VIVS or BFRGW more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of 0.00% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% Bullfrog AI N/A N/A N/A

Do analysts prefer VIVS or OABIW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, VIVS or OABIW?

OmniAb has higher revenue and earnings than VivoSim Labs. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VivoSim Labs $130K 22.98 -$13.84M -$4.47 N/A OmniAb $38.46M N/A N/A N/A N/A

Is VIVS or OABIW more profitable?

OmniAb has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. OmniAb's return on equity of 0.00% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% OmniAb N/A N/A N/A

Do analysts prefer VIVS or TBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is VIVS or TBIO more profitable?

Telesis Bio has a net margin of -336.59% compared to VivoSim Labs' net margin of -11,016.07%. Telesis Bio's return on equity of 0.00% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% Telesis Bio -336.59% N/A -61.89%

VivoSim Labs (VIVS) Competitors

$0.17 -0.01 (-3.39%)

As of 10:07 AM Eastern

Compare

VIVS vs. BFRG, ISPC, BFRGW, OABIW, and TBIO

Should you buy VivoSim Labs stock or one of its competitors? VivoSim Labs's main competitors and comparable companies include Bullfrog AI (BFRG), iSpecimen (ISPC), Bullfrog AI (BFRGW), OmniAb (OABIW), and Telesis Bio (TBIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does VivoSim Labs compare to Bullfrog AI?

Bullfrog AI (NASDAQ:BFRG) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Bullfrog AI has higher earnings, but lower revenue than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by insiders. Comparatively, 1.0% of VivoSim Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

In the previous week, VivoSim Labs had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 5 mentions for VivoSim Labs and 4 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
VivoSim Labs	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bullfrog AI has a beta of -2.73, indicating that its stock price is 373% less volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Bullfrog AI beats VivoSim Labs on 8 of the 14 factors compared between the two stocks.

How does VivoSim Labs compare to iSpecimen?

iSpecimen (NASDAQ:ISPC) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

iSpecimen has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market.

iSpecimen has higher revenue and earnings than VivoSim Labs. VivoSim Labs is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.48	-$10.49M	-$56.44	N/A
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A

iSpecimen has a net margin of -2,445.40% compared to VivoSim Labs' net margin of -11,016.07%. iSpecimen's return on equity of -524.39% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-2,445.40%	-524.39%	-140.42%
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Comparatively, 1.0% of VivoSim Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, VivoSim Labs had 3 more articles in the media than iSpecimen. MarketBeat recorded 5 mentions for VivoSim Labs and 2 mentions for iSpecimen. VivoSim Labs' average media sentiment score of 0.90 beat iSpecimen's score of 0.90 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iSpecimen	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
VivoSim Labs	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

iSpecimen beats VivoSim Labs on 9 of the 13 factors compared between the two stocks.

How does VivoSim Labs compare to Bullfrog AI?

VivoSim Labs (NASDAQ:VIVS) and Bullfrog AI (NASDAQ:BFRGW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of 0.00% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
Bullfrog AI	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bullfrog AI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, VivoSim Labs had 3 more articles in the media than Bullfrog AI. MarketBeat recorded 5 mentions for VivoSim Labs and 2 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.90 beat Bullfrog AI's score of -0.11 indicating that VivoSim Labs is being referred to more favorably in the media.

Company	Overall Sentiment
VivoSim Labs	Positive
Bullfrog AI	Neutral

Bullfrog AI has higher revenue and earnings than VivoSim Labs.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A
Bullfrog AI	$298.80K	N/A	N/A	N/A	N/A

8.2% of VivoSim Labs shares are owned by institutional investors. 1.0% of VivoSim Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

VivoSim Labs beats Bullfrog AI on 5 of the 9 factors compared between the two stocks.

How does VivoSim Labs compare to OmniAb?

VivoSim Labs (NASDAQ:VIVS) and OmniAb (NASDAQ:OABIW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

OmniAb has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. OmniAb's return on equity of 0.00% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
OmniAb	N/A	N/A	N/A

In the previous week, VivoSim Labs had 4 more articles in the media than OmniAb. MarketBeat recorded 5 mentions for VivoSim Labs and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat VivoSim Labs' score of 0.90 indicating that OmniAb is being referred to more favorably in the news media.

Company	Overall Sentiment
VivoSim Labs	Positive
OmniAb	Very Positive

8.2% of VivoSim Labs shares are owned by institutional investors. 1.0% of VivoSim Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

OmniAb has higher revenue and earnings than VivoSim Labs.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A
OmniAb	$38.46M	N/A	N/A	N/A	N/A

Summary

OmniAb beats VivoSim Labs on 5 of the 9 factors compared between the two stocks.

How does VivoSim Labs compare to Telesis Bio?

VivoSim Labs (NASDAQ:VIVS) and Telesis Bio (NASDAQ:TBIO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Telesis Bio has a net margin of -336.59% compared to VivoSim Labs' net margin of -11,016.07%. Telesis Bio's return on equity of 0.00% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
Telesis Bio	-336.59%	N/A	-61.89%

In the previous week, VivoSim Labs had 5 more articles in the media than Telesis Bio. MarketBeat recorded 5 mentions for VivoSim Labs and 0 mentions for Telesis Bio. VivoSim Labs' average media sentiment score of 0.90 beat Telesis Bio's score of 0.00 indicating that VivoSim Labs is being referred to more favorably in the media.

Company	Overall Sentiment
VivoSim Labs	Positive
Telesis Bio	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

VivoSim Labs has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.58, suggesting that its share price is 158% more volatile than the broader market.

VivoSim Labs has higher earnings, but lower revenue than Telesis Bio. VivoSim Labs is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

8.2% of VivoSim Labs shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 1.0% of VivoSim Labs shares are held by insiders. Comparatively, 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Telesis Bio beats VivoSim Labs on 8 of the 14 factors compared between the two stocks.

Get VivoSim Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIVS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VIVS vs. The Competition

Export

Metric	VivoSim Labs	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.89M	$10.60B	$7.27B	$13.26B
Dividend Yield	N/A	1.45%	2.53%	22.58%
P/E Ratio	-0.04	32.47	275.62	25.98
Price / Sales	22.21	105.75	583.29	80.65
Price / Cash	N/A	27.28	27.30	36.12
Price / Book	-0.41	6.34	10.83	6.14
Net Income	-$13.84M	$56.67B	$3.50B	$381.00M
7 Day Performance	-15.70%	-3.70%	-1.40%	-1.62%
1 Month Performance	-38.54%	7.81%	-4.19%	-3.54%
1 Year Performance	-94.28%	30.84%	6.83%	1.14%

VivoSim Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VIVS VivoSim Labs	0.5523 of 5 stars	$0.17 -3.4%	N/A	-94.1%	$2.89M	$130K	N/A	11
BFRG Bullfrog AI	1.4395 of 5 stars	$0.63 +4.5%	N/A	-51.1%	$11.15M	$120K	N/A	17	Short Interest Increase Gap Up
ISPC iSpecimen	0.8601 of 5 stars	$1.14 -3.4%	N/A	-96.7%	$2.97M	$1.93M	N/A	7	News Coverage Gap Up
BFRGW Bullfrog AI	N/A	$0.16 +5.4%	N/A	-71.8%	$0.00	$298.80K	N/A	9	News Coverage Short Interest Increase Gap Up
OABIW OmniAb	N/A	$0.27 -25.7%	N/A	+129.2%	$0.00	$38.46M	N/A	89	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VIVS) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VivoSim Labs (VIVS) Competitors

VIVS vs. BFRG, ISPC, BFRGW, OABIW, and TBIO

How does VivoSim Labs compare to Bullfrog AI?

Summary

How does VivoSim Labs compare to iSpecimen?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Summary

How does VivoSim Labs compare to OmniAb?

Summary

How does VivoSim Labs compare to Telesis Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VIVS vs. The Competition

VivoSim Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VivoSim Labs (VIVS) Competitors

VIVS vs. BFRG, ISPC, BFRGW, OABIW, and TBIO

How does VivoSim Labs compare to Bullfrog AI?

Which has higher earnings & valuation, BFRG or VIVS?

Do insiders and institutionals have more ownership in BFRG or VIVS?

Is BFRG or VIVS more profitable?

Does the media prefer BFRG or VIVS?

Which has more volatility and risk, BFRG or VIVS?

Do analysts rate BFRG or VIVS?

Summary

How does VivoSim Labs compare to iSpecimen?

Do analysts rate ISPC or VIVS?

Which has more risk and volatility, ISPC or VIVS?

Which has stronger earnings and valuation, ISPC or VIVS?

Is ISPC or VIVS more profitable?

Do institutionals and insiders have more ownership in ISPC or VIVS?

Does the media prefer ISPC or VIVS?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Is VIVS or BFRGW more profitable?

Do analysts rate VIVS or BFRGW?

Does the media prefer VIVS or BFRGW?

Which has preferable earnings & valuation, VIVS or BFRGW?

Do insiders and institutionals hold more shares of VIVS or BFRGW?

Summary

How does VivoSim Labs compare to OmniAb?

Is VIVS or OABIW more profitable?

Does the media favor VIVS or OABIW?

Do institutionals & insiders believe in VIVS or OABIW?

Do analysts prefer VIVS or OABIW?

Which has preferable earnings & valuation, VIVS or OABIW?

Summary

How does VivoSim Labs compare to Telesis Bio?

Is VIVS or TBIO more profitable?

Does the media refer more to VIVS or TBIO?

Do analysts prefer VIVS or TBIO?

Which has more risk and volatility, VIVS or TBIO?

Which has higher valuation and earnings, VIVS or TBIO?

Do institutionals & insiders believe in VIVS or TBIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VIVS vs. The Competition

VivoSim Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools